Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renate Kain

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Presse Medicale (Paris, France : 1983)|March 5, 2013
L29. Relevance of anti-LAMP-2 in vasculitis: why the controversyRenate Kain
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2016
HistopathologyRenate Kain
Pathologie (Heidelberg, Germany)|May 28, 2024
[Renal involvement in systemic diseases]Renate Kain
Nature Reviews. Nephrology|October 27, 2009
Nephrotic syndrome: a watershed in the understanding of membranous nephropathyAndrew Rees, Renate Kain
Rheumatology (Oxford, England)|March 12, 2025
Spatial transcriptomics in glomerular diseasesRenate Kain, André Oszwald
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2008
Kim-1/Tim-1: from biomarker to therapeutic target?Andrew J Rees, Renate Kain
Current Opinion in Rheumatology|November 22, 2012
What is the evidence for antibodies to LAMP-2 in the pathogenesis of ANCA associated small vessel vasculitis?Renate Kain, Andrew J Rees
Journal of the American Society of Nephrology : JASN|October 19, 2007
Interferon-beta: a novel way to treat nephrotic syndrome?Andrew J Rees, Renate Kain
Journal of the American Society of Nephrology : JASN|April 9, 2022
A View on Cathepsin C as a Target for Therapy in AAVRenate Kain, Maja C Nackenhorst
Journal of the American Society of Nephrology : JASN|March 13, 2015
Coming of Age--CC Chemokine Ligand 18 in ANCA-Associated VasculitisRenate Kain, Andrew J Rees
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Presse Medicale (Paris, France : 1983)|March 5, 2013
L29. Relevance of anti-LAMP-2 in vasculitis: why the controversyRenate Kain
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2016
HistopathologyRenate Kain
Pathologie (Heidelberg, Germany)|May 28, 2024
[Renal involvement in systemic diseases]Renate Kain
Nature Reviews. Nephrology|October 27, 2009
Nephrotic syndrome: a watershed in the understanding of membranous nephropathyAndrew Rees, Renate Kain
Rheumatology (Oxford, England)|March 12, 2025
Spatial transcriptomics in glomerular diseasesRenate Kain, André Oszwald
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2008
Kim-1/Tim-1: from biomarker to therapeutic target?Andrew J Rees, Renate Kain
Current Opinion in Rheumatology|November 22, 2012
What is the evidence for antibodies to LAMP-2 in the pathogenesis of ANCA associated small vessel vasculitis?Renate Kain, Andrew J Rees
Journal of the American Society of Nephrology : JASN|October 19, 2007
Interferon-beta: a novel way to treat nephrotic syndrome?Andrew J Rees, Renate Kain
Journal of the American Society of Nephrology : JASN|April 9, 2022
A View on Cathepsin C as a Target for Therapy in AAVRenate Kain, Maja C Nackenhorst
Journal of the American Society of Nephrology : JASN|March 13, 2015
Coming of Age--CC Chemokine Ligand 18 in ANCA-Associated VasculitisRenate Kain, Andrew J Rees
Pageof 12